These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 31018854)
1. Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand. Mei L; Zhang J; He K; Zhang J J Hematol Oncol; 2019 Apr; 12(1):43. PubMed ID: 31018854 [TBL] [Abstract][Full Text] [Related]
2. PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness. Gralewska P; Gajek A; Marczak A; Mikuła M; Ostrowski J; Śliwińska A; Rogalska A Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352723 [TBL] [Abstract][Full Text] [Related]
3. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer. Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K Cells; 2020 Jan; 9(1):. PubMed ID: 31963582 [TBL] [Abstract][Full Text] [Related]
4. Selective Inhibition of ATM-dependent Double-strand Break Repair and Checkpoint Control Synergistically Enhances the Efficacy of ATR Inhibitors. Turchick A; Zimmermann A; Chiu LY; Dahmen H; Elenbaas B; Zenke FT; Blaukat A; Vassilev LT Mol Cancer Ther; 2023 Jul; 22(7):859-872. PubMed ID: 37079339 [TBL] [Abstract][Full Text] [Related]
5. A Tale of Two Checkpoints: ATR Inhibition and PD-(L)1 Blockade. Ngoi NYL; Peng G; Yap TA Annu Rev Med; 2022 Jan; 73():231-250. PubMed ID: 34644155 [TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells. Kim HJ; Min A; Im SA; Jang H; Lee KH; Lau A; Lee M; Kim S; Yang Y; Kim J; Kim TY; Oh DY; Brown J; O'Connor MJ; Bang YJ Int J Cancer; 2017 Jan; 140(1):109-119. PubMed ID: 27501113 [TBL] [Abstract][Full Text] [Related]
8. The ATM and Rad3-Related (ATR) Protein Kinase Pathway Is Activated by Herpes Simplex Virus 1 and Required for Efficient Viral Replication. Edwards TG; Bloom DC; Fisher C J Virol; 2018 Mar; 92(6):. PubMed ID: 29263259 [TBL] [Abstract][Full Text] [Related]
9. Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations? Bradbury A; Hall S; Curtin N; Drew Y Pharmacol Ther; 2020 Mar; 207():107450. PubMed ID: 31836456 [TBL] [Abstract][Full Text] [Related]
10. ATR Inhibition in Advanced Urothelial Carcinoma. Leibrandt RC; Tu MJ; Yu AM; Lara PN; Parikh M Clin Genitourin Cancer; 2023 Apr; 21(2):203-207. PubMed ID: 36604210 [TBL] [Abstract][Full Text] [Related]
11. Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor. Manavella DD; McNamara B; Harold J; Bellone S; Hartwich TMP; Yang-Hartwich Y; Mutlu L; Zipponi M; Demirkiran C; Verzosa MS; Altwerger G; Ratner E; Huang GS; Clark M; Andikyan V; Azodi M; Schwartz PE; Dottino PR; Choi J; Alexandrov LB; Buza N; Hui P; Santin AD Gynecol Oncol; 2023 Feb; 169():98-105. PubMed ID: 36525930 [TBL] [Abstract][Full Text] [Related]
12. ATR-Chk1 activation mitigates replication stress caused by mismatch repair-dependent processing of DNA damage. Gupta D; Lin B; Cowan A; Heinen CD Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1523-1528. PubMed ID: 29378956 [TBL] [Abstract][Full Text] [Related]
13. Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer. Gralewska P; Gajek A; Marczak A; Rogalska A J Hematol Oncol; 2020 Apr; 13(1):39. PubMed ID: 32316968 [TBL] [Abstract][Full Text] [Related]
14. Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition. Haynes B; Murai J; Lee JM Cancer Treat Rev; 2018 Dec; 71():1-7. PubMed ID: 30269007 [TBL] [Abstract][Full Text] [Related]
15. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor. Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154 [TBL] [Abstract][Full Text] [Related]
16. Exploiting replicative stress in gynecological cancers as a therapeutic strategy. Ngoi NY; Sundararajan V; Tan DS Int J Gynecol Cancer; 2020 Aug; 30(8):1224-1238. PubMed ID: 32571890 [TBL] [Abstract][Full Text] [Related]
18. Synergistic lethality between auranofin-induced oxidative DNA damage and ATR inhibition in cancer cells. Zhang S; Zhao Y; Wang X; Qi C; Tian J; Zou Z Life Sci; 2023 Nov; 332():122131. PubMed ID: 37778414 [TBL] [Abstract][Full Text] [Related]
19. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3. Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y J Virol; 2019 May; 93(9):. PubMed ID: 30787154 [TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibitors of Ataxia Telangiectasia and Rad3 related kinase (ATR) sensitize lymphoma cells to UVA radiation. Biskup E; Naym DG; Gniadecki R J Dermatol Sci; 2016 Dec; 84(3):239-247. PubMed ID: 27743911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]